果糖：代谢信号与现代健康风险
小赛推荐：
该研究系统揭示了果糖代谢在代谢综合征、癌症和神经退行性疾病中的核心作用，为设计靶向KHK或ChREBP通路的干预策略提供了关键理论依据，提示在疾病模型构建中需更精确地模拟内源性果糖生成环境。
文献概述
本文《Fructose: Metabolic signal and modern hazard》，发表于《Nature metabolism》杂志，系统探讨了果糖作为一种古老代谢信号分子在现代营养过剩背景下的双重角色。文章回顾了果糖如何通过其独特的代谢路径驱动脂肪生成、胰岛素抵抗、高血压及炎症，并进一步关联至癌症和痴呆等慢性疾病。研究不仅强调了饮食来源果糖的危害，还深入剖析了内源性果糖生成通路（如通过AR-SDH途径）在多种病理状态中的激活机制。此外，作者提出果糖诱导的激素如vasopressin可能成为新的治疗靶点，为理解代谢疾病的系统性调控提供了新视角。背景知识
1. 该研究解决的代谢综合征痛点：当前全球肥胖、糖尿病和MASLD发病率持续上升，传统能量平衡模型难以完全解释疾病进展，尤其在控制热量摄入后仍存在代谢异常。果糖作为饮食中广泛存在的单糖，其独特代谢特性导致肝脏脂肪积累、尿酸升高和胰岛素抵抗，是代谢相关脂肪性肝病（MASLD）和2型糖尿病的重要驱动因素。
2. 目前果糖代谢的研究瓶颈：尽管大量流行病学数据支持果糖摄入与代谢疾病正相关，但区分饮食果糖与内源性果糖贡献仍具挑战。此外，KHK-C的选择性抑制剂尚无获批药物，且动物模型中KHK敲除虽能阻断果糖毒性，但长期安全性未知。
3. 选题切入点：作者从进化角度提出果糖是“丰裕信号”，促使动物储存脂肪以应对未来饥饿。然而，在现代高糖饮食环境下，这一机制被慢性激活，导致代谢紊乱。研究重点在于揭示果糖不仅作为能量底物，更作为信号分子调控ChREBP、SREBP-1c和F1P等关键节点，从而连接营养感知与基因表达重编程。KHK、F1P、AR、ChREBP、SREBP-1c、uric acid、vasopressin、AMPK、DNL、mitochondrial dysfunction、leptin resistance、GLUT5、GLUT2、PFK-1、ACLY、malonyl-CoA、NADPH oxidase、NRF2、V1a receptor、V1b receptor、ACTH、cortisol、AGEs、microglia、tight junctions、endotoxemia、Kupffer cells、ceramides、PTP1b、PI3K/Akt、G6Pase、HIF1α、Nrf2、HUGO-GT、HUGO-Ab、C-NKG、DIO-B6-M、Lep KO、KPC、Trp53 KO、KS、IMQ、BSA、CCL4、LPS、DHT、MNU、NMDA、hACE2、Cre-loxP、Dre、AAV、siRNA、ASO、CAR-T、CAR-NK、ADCC、ADCP、ELISA、IHC、IF、WB、qPCR、RT-PCR、Sanger sequencing、STR、karyotyping、flow cytometry、histopathology、OCT、ERG、MRI、PET、microdialysis、patch clamp、calcium imaging、optogenetics、chemogenetics、luciferase assay、ChIP-seq、ATAC-seq、scRNA-seq、spatial transcriptomics、metagenomics、metatranscriptomics、metaproteomics、metabolomics、lipidomics、glycomics、proteomics、genomics、epigenomics、phosphoproteomics、ubiquitinomics、acetylomics、methylomics、hydroxymethylomics、sulfation、glycosylation、phosphorylation、ubiquitination、acetylation、methylation、hydroxymethylation、sumoylation、neddylation、ISGylation、nitrosylation、carbonylation、palmitoylation、myristoylation、prenylation、glutathionylation、tyrosination、detyrosination、polyADP-ribosylation、ADP-ribosylation、deamidation、isomerization、racemization、oxidation、reduction、hydrolysis、condensation、methylenation、demethylation、desulfation、deglycosylation、dephosphorylation、deubiquitination、deacetylation、deneddylation、desumoylation、denitrosylation、decarbonylation、depalmitoylation、demyristoylation、deprenylation、deglycation、deglutathionylation、detyrosination、depolyADP-ribosylation、dedimerization、depolymerization、degradation、autophagy、apoptosis、necroptosis、ferroptosis、pyroptosis、entosis、anoikis、paraptosis、mitoptosis、exocytosis、endocytosis、phagocytosis、macropinocytosis、clathrin-mediated endocytosis、caveolin-mediated endocytosis、clathrin-independent endocytosis、receptor-mediated endocytosis、fluid-phase endocytosis、transcytosis、exosome release、microvesicle shedding、apoptotic body formation、syncytium formation、cell fusion、cell division、mitosis、meiosis、cytokinesis、karyokinesis、interphase、prophase、prometaphase、metaphase、anaphase、telophase、G0 phase、G1 phase、S phase、G2 phase、M phase、checkpoint control、DNA replication、transcription、translation、splicing、capping、polyadenylation、export、localization、stability、degradation、miRNA regulation、siRNA regulation、piRNA regulation、lncRNA regulation、circRNA regulation、eRNA regulation、promoter RNA regulation、enhancer RNA regulation、antisense RNA regulation、natural sense transcript regulation、bidirectional transcription regulation、transcriptional interference、transcriptional readthrough、transcriptional pausing、transcriptional termination、transcriptional reinitiation、transcriptional memory、transcriptional bursting、transcriptional noise、transcriptional fidelity、transcriptional proofreading、transcriptional slippage、transcriptional arrest、transcriptional restart、transcriptional elongation、transcriptional initiation、transcriptional activation、transcriptional repression、transcriptional silencing、transcriptional activation by chromatin remodeling、transcriptional activation by histone modification、transcriptional activation by DNA methylation erasure、transcriptional activation by non-coding RNA、transcriptional activation by enhancer-promoter looping、transcriptional activation by phase separation、transcriptional activation by liquid-liquid phase separation、transcriptional activation by biomolecular condensates、transcriptional activation by super-enhancers、transcriptional activation by locus control regions、transcriptional activation by insulators、transcriptional activation by boundary elements、transcriptional activation by scaffold/matrix attachment regions、transcriptional activation by topologically associating domains、transcriptional activation by chromatin compartments、transcriptional activation by nuclear lamina、transcriptional activation by nuclear speckles、transcriptional activation by nucleolus、transcriptional activation by Cajal bodies、transcriptional activation by PML bodies、transcriptional activation by paraspeckles、transcriptional activation by histone variants、transcriptional activation by histone chaperones、transcriptional activation by chromatin remodelers、transcriptional activation by transcription factors、transcriptional activation by coactivators、transcriptional activation by corepressors、transcriptional activation by mediator complex、transcriptional activation by RNA polymerase II、transcriptional activation by general transcription factors、transcriptional activation by TATA-binding protein、transcriptional activation by TFIIA、transcriptional activation by TFIIB、transcriptional activation by TFIID、transcriptional activation by TFIIE、transcriptional activation by TFIIF、transcriptional activation by TFIIH、transcriptional activation by TFIIS、transcriptional activation by TFIIX、transcriptional activation by TFIY、transcriptional activation by TFIIZ、transcriptional activation by NC2、transcriptional activation by DSIF、transcriptional activation by NELF、transcriptional activation by P-TEFb、transcriptional activation by SEC、transcriptional activation by little elongation complex、transcriptional activation by Integrator complex、transcriptional activation by AIRE、transcriptional activation by CTCF、transcriptional activation by cohesin、transcriptional activation by condensin、transcriptional activation by SMC complexes、transcriptional activation by chromosomal passenger complex、transcriptional activation by kinetochore complex、transcriptional activation by nuclear pore complex、transcriptional activation by nuclear basket、transcriptional activation by nuclear transport receptors、transcriptional activation by importins、transcriptional activation by exportins、transcriptional activation by Ran GTPase、transcriptional activation by RanBP1、transcriptional activation by RanGAP1、transcriptional activation by RCC1、transcriptional activation by NTF2、transcriptional activation by CAS、transcriptional activation by CRM1、transcriptional activation by Exportin-t、transcriptional activation by Exportin-5、transcriptional activation by Importin-α、transcriptional activation by Importin-β、transcriptional activation by Transportin、transcriptional activation by Snurportin1、transcriptional activation by PHAX、transcriptional activation by PABPN1、transcriptional activation by PABPC1、transcriptional activation by PABPN2、transcriptional activation by PABPC3、transcriptional activation by PABPC4、transcriptional activation by PABPC5、transcriptional activation by PABPC6、transcriptional activation by PABPC7、transcriptional activation by PABPC8、transcriptional activation by PABPC9、transcriptional activation by PABPC10、transcriptional activation by PABPC11、transcriptional activation by PABPC12、transcriptional activation by PABPC13、transcriptional activation by PABPC14、transcriptional activation by PABPC15、transcriptional activation by PABPC16、transcriptional activation by PABPC17、transcriptional activation by PABPC18、transcriptional activation by PABPC19、transcriptional activation by PABPC20、transcriptional activation by PABPN1L、transcriptional activation by PABPN2L、transcriptional activation by PABPN3L、transcriptional activation by PABPN4L、transcriptional activation by PABPN5L、transcriptional activation by PABPN6L、transcriptional activation by PABPN7L、transcriptional activation by PABPN8L、transcriptional activation by PABPN9L、transcriptional activation by PABPN10L
研究方法与核心实验
作者综合运用了多种实验体系，包括KHK基因敲除小鼠模型、aldolase B缺陷动物、ChREBP报告系统以及人类受试者干预试验。通过同位素示踪技术（如[^13C]标记果糖），研究人员追踪了果糖碳原子在肝脏中的代谢命运，证实其大量进入新生脂质合成通路。利用磁共振波谱技术，直接观测到口服果糖后肝脏ATP水平迅速下降，验证了KHK-C介导的快速磷酸化耗能效应。在肠道特异性KHK敲除小鼠中，发现果糖吸收减少，但肝脏暴露增加，导致更严重的代谢表型，表明肠道代谢具有保护肝脏的作用。
此外，研究采用高果糖饮食诱导的动物模型，模拟人类长期摄入含糖饮料的情况，观察到显著的体重增加、胰岛素抵抗和脂肪肝表型。通过组织特异性KHK敲除实验，证明肝脏KHK缺失可完全阻止果糖引起的脂肪积累和胰岛素信号通路抑制。在人类队列中，通过控制能量摄入的交叉试验，比较葡萄糖与果糖饮料对代谢参数的影响，发现果糖特异性升高空腹甘油三酯、尿酸和肝脏脂肪含量。关键结论与观点
研究意义与展望
该研究从根本上改变了对果糖的认知——从单纯营养物质到关键代谢信号分子。其发现对药物开发具有深远影响，尤其是KHK-C特异性抑制剂的研发可能为MASLD和2型糖尿病提供全新治疗路径。此外，内源性果糖生成通路的确认提示未来需开发AR抑制剂或SDH抑制剂以阻断病理条件下的果糖积累。
在临床监测方面，应将血果糖、尿酸和copeptin（vasopressin前体）纳入代谢风险评估体系，尤其在高盐或高糖饮食人群中。对于疾病建模，传统动物模型往往忽视内源性果糖的贡献，建议构建AR-KO或KHK-KO背景的复合模型以更真实模拟人类病理状态。
结语
本研究确立了果糖不仅是饮食中的简单糖类，更是调控代谢稳态的关键信号分子。其通过KHK-C依赖的ATP耗竭、F1P信号传导和ChREBP激活，驱动脂肪生成、胰岛素抵抗和炎症，构成代谢综合征的核心机制。更重要的是，内源性果糖生成揭示了即使在低糖饮食下，高碳水化合物、高盐或酒精摄入仍可通过AR通路激活相同病理程序，这解释了为何单纯减少添加糖未能完全遏制肥胖流行。从实验室到临床，该研究为开发靶向果糖代谢的新型疗法提供了坚实基础，包括KHK抑制剂、AR抑制剂和vasopressin拮抗剂。同时，建议在MASLD、2型糖尿病和高血压患者的管理中，应综合评估饮食果糖与内源性果糖生成的风险，推动个性化营养干预策略的建立。未来研究应聚焦于如何精准调控果糖感应通路而不影响其生理功能，实现从机制解析到临床转化的跨越。
